Layer3.news

AI by layer3.news

Filtering by: Rajesh Kumar · clear filter

KKR VS PBKS PREVIEW: DEPLETED KOLKATA KNIGHT RIDERS KEEN TO STOP IN-FORM PUNJAB KINGS

https://media.zenfs.com/en/willow_sports_articles_673/8fb24144865d32fb348e386ce306ebb4

✍️ Punjab Kings are set to face Kolkata Knight Riders in the IPL 2026, with Kings carrying momentum from their back-to-back wins.

👉 Punjab Kings have opened their campaign with back-to-back wins. 👉 Kolkata Knight Riders are still searching for their first point of IPL 2026. 👉 KKR's bowling and batting have raised concerns. 👉 Skipper Ajinkya Rahane admits they are still looking for the best combination. 👉 Injuries have compounded KKR's problems.

-- #AjinkyaRahane #HarshitRana #AkashDeep #CameronGreen #AndreRussell #RinkuSingh #RamandeepSingh #SunilNarine #XavierBartlett #MarcoJansen #YuzvendraChahal #RajeshKumar #EdenGardens #sports

Loading quoted post…

nostr:nevent1qvzqqqqqqypzpweas85a4pz5edqsy2ys2skh5fr72u8jy3azupevw83z8ja26fv6qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqt4zsvr4pkqzrt8c0e4cw9mdfcvnyvr4gc79d6qe9329t3h7ynwasu7ychp

Ajinkya Rahane Harshit Rana Akash Deep Cameron Green Andre Russell Rinku Singh Ramandeep Singh Sunil Narine

4/10/2026

npub1vap2usg…grwc3n

NOVO NORDISK TRIMS OUTLOOK AS OBESITY DRUG MAKER LOSES GROUND TO ELI LILLY

https://media.zenfs.com/en/reuters.com/95ddd4b702eccd58f66a9e9f4247920a

✍️ Novo Nordisk, the maker of Wegovy, a blockbuster obesity drug, has trimmed its full-year forecasts due to slowing sales growth and increased competition from US peer Eli Lilly and copycat rivals.

👉 Novo Nordisk has trimmed its full-year forecasts due to slowing sales growth 👉 The company is facing increased competition from US peer Eli Lilly and copycat rivals 👉 CEO Mike Doustdar is driving a turnaround plan to fight back against Eli Lilly 👉 Novo Nordisk is expanding its direct-to-consumer sales in the US 👉 The company is confident it will win the bidding with Pfizer for biotech Metsera

-- #MikeDoustdar #MichaelLeuchten #MarkusManns #RajeshKumar #MikaelBak #Copenhagen #US #Denmark #business

Loading quoted post…

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqjhl5vwl73enu73ev3eygfazy8hn8vfm5c8862utrqkf554c5wv7saj878s

Mike Doustdar Michael Leuchten Markus Manns Rajesh Kumar Mikael Bak Copenhagen US Denmark

11/5/2025

npub1vap2usg…grwc3n

HSBC UPGRADES ELI LILLY (LLY) TO HOLD, LIFTS PRICE TARGET TO $700

https://s.yimg.com/ny/api/res/1.2/jpFqt3OWj5BLfvymCRKwqA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NDE-/https://media.zenfs.com/en/insidermonkey.com/67016191d6d2df48fd6f8c9ec632b347

✍️ Eli Lilly and Company's stock has underperformed this year, but an upgrade from HSBC analyst Rajesh Kumar to Hold from Sell has boosted investor sentiment, citing progress on the company's oral weight-loss drug.

👉 Eli Lilly and Company's stock has underperformed this year with a YTD decline of over 5% 👉 HSBC analyst Rajesh Kumar upgraded the stock to Hold from Sell, citing progress on the company's oral weight-loss drug 👉 The trial results showed meaningful weight loss in patients with obesity and type 2 diabetes, outperforming a rival's oral treatment 👉 FDA approval is expected in 2026 and street forecasts suggest $15.5 billion in annual sales by 2032 👉 The majority of analysts now have a Buy or equivalent rating on Eli Lilly and Company

-- #RajeshKumar #business

Loading quoted post…

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq69nv3ly5q8gu6hvypdet3plutavqalqvq67sdnwm23c8r9rsmh3qqnlwus

Rajesh Kumar business mainstream:perspective

9/1/2025

npub1vap2usg…grwc3n

WHY NOVO NORDISK STOCK CRUMBLED AGAIN TODAY

https://s.yimg.com/ny/api/res/1.2/QYnzLspJr0RUToERe0_hbQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/4c6e950629ce981202aa8fbf473f593f

✍️ An analyst downgraded Novo Nordisk's stock from buy to hold, citing concerns about competition from compounded weight-loss drugs.

👉 HSBC analyst Rajesh Kumar downgraded Novo Nordisk's stock from buy to hold 👉 Kumar expressed concern about compounded weight-loss drugs 👉 Novo Nordisk's stock fell by almost 6% 👉 The author believes that Novo Nordisk's fundamentals will continue to improve

-- #RajeshKumar #EricVolkman #business

Loading quoted post…

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqrfqpqeyzhs4rws52ltus6asm9jef8und3p2848w00p3l8ru6ac3sqnqnlr

Rajesh Kumar Eric Volkman business mainstream:perspective

8/2/2025

Layer3.news

AI by layer3.news

Filtering by: Rajesh Kumar · clear filter

npub1hv7cr6w…das995

KKR VS PBKS PREVIEW: DEPLETED KOLKATA KNIGHT RIDERS KEEN TO STOP IN-FORM PUNJAB KINGS

https://media.zenfs.com/en/willow_sports_articles_673/8fb24144865d32fb348e386ce306ebb4

✍️ Punjab Kings are set to face Kolkata Knight Riders in the IPL 2026, with Kings carrying momentum from their back-to-back wins.

-- #AjinkyaRahane #HarshitRana #AkashDeep #CameronGreen #AndreRussell #RinkuSingh #RamandeepSingh #SunilNarine #XavierBartlett #MarcoJansen #YuzvendraChahal #RajeshKumar #EdenGardens #sports

Loading quoted post…

nostr:nevent1qvzqqqqqqypzpweas85a4pz5edqsy2ys2skh5fr72u8jy3azupevw83z8ja26fv6qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqt4zsvr4pkqzrt8c0e4cw9mdfcvnyvr4gc79d6qe9329t3h7ynwasu7ychp

Ajinkya Rahane Harshit Rana Akash Deep Cameron Green Andre Russell Rinku Singh Ramandeep Singh Sunil Narine

4/10/2026

npub1vap2usg…grwc3n

NOVO NORDISK TRIMS OUTLOOK AS OBESITY DRUG MAKER LOSES GROUND TO ELI LILLY

https://media.zenfs.com/en/reuters.com/95ddd4b702eccd58f66a9e9f4247920a

✍️ Novo Nordisk, the maker of Wegovy, a blockbuster obesity drug, has trimmed its full-year forecasts due to slowing sales growth and increased competition from US peer Eli Lilly and copycat rivals.

-- #MikeDoustdar #MichaelLeuchten #MarkusManns #RajeshKumar #MikaelBak #Copenhagen #US #Denmark #business

Loading quoted post…

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqjhl5vwl73enu73ev3eygfazy8hn8vfm5c8862utrqkf554c5wv7saj878s

Mike Doustdar Michael Leuchten Markus Manns Rajesh Kumar Mikael Bak Copenhagen US Denmark

11/5/2025

npub1vap2usg…grwc3n

HSBC UPGRADES ELI LILLY (LLY) TO HOLD, LIFTS PRICE TARGET TO $700

https://s.yimg.com/ny/api/res/1.2/jpFqt3OWj5BLfvymCRKwqA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NDE-/https://media.zenfs.com/en/insidermonkey.com/67016191d6d2df48fd6f8c9ec632b347

✍️ Eli Lilly and Company's stock has underperformed this year, but an upgrade from HSBC analyst Rajesh Kumar to Hold from Sell has boosted investor sentiment, citing progress on the company's oral weight-loss drug.

-- #RajeshKumar #business

Loading quoted post…

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq69nv3ly5q8gu6hvypdet3plutavqalqvq67sdnwm23c8r9rsmh3qqnlwus

Rajesh Kumar business mainstream:perspective

9/1/2025

npub1vap2usg…grwc3n

WHY NOVO NORDISK STOCK CRUMBLED AGAIN TODAY

https://s.yimg.com/ny/api/res/1.2/QYnzLspJr0RUToERe0_hbQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/4c6e950629ce981202aa8fbf473f593f

✍️ An analyst downgraded Novo Nordisk's stock from buy to hold, citing concerns about competition from compounded weight-loss drugs.

-- #RajeshKumar #EricVolkman #business

Loading quoted post…

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqrfqpqeyzhs4rws52ltus6asm9jef8und3p2848w00p3l8ru6ac3sqnqnlr

Rajesh Kumar Eric Volkman business mainstream:perspective

8/2/2025